We are a leading pharmaceutical company in Latin America with over 40 years of experience and sustained growth in the region. Our purpose is to bring innovative treatments closer to improve …

Por más de 40 años en Adium hemos consolidado un amplio portafolio para ofrecerles a médicos y pacientes de Latinoamérica soluciones terapéuticas innovadoras y de alta calidad con el …

We are a leading pharmaceutical company with over 40 years of experience and presence in 18 countries in Latin America. To bring innovative treatments closer to improve the quality of life …

To be the leading pharmaceutical company in Latin America, enabling teams to develop and grow, providing quality and innovative treatments to physicians and patients, contributing to …

We are a leading pharmaceutical company, dedicated to patients, physicians and the entire Latin American community. We are present in 17 countries, supported by a committed and …

PharmaMar signs a new agreement with Adium to commercialize Zepzelca® (lurbinectedin) in Latin America. PharmaMar will receive an upfront payment of €2 million and is eligible for …

Information on valuation, funding, cap tables, investors, and executives for Adium Pharma. Use the PitchBook Platform to explore the full profile.

At Adium, we offer a broad portfolio for the treatment of hypertension, hypercholesterolemia, and anticoagulation. Diabetes has become one of the main causes of death and disability in Latin …

2022年2月23日 · Moderna has partnered with Latin America-based pharmaceutical company Adium Pharma to support the commercialisation of its Covid-19 vaccine, Spikevax, across the …

2022年2月23日 · Moderna and Latin American firm Adium Pharma have entered a distribution service agreement, which will aid in the commercialisation of the former’s Covid-19 vaccine, …